ASCENDIA PHARMA Trademark

Trademark Overview

On Friday, July 5, 2013, a trademark application was filed for ASCENDIA PHARMA with the United States Patent and Trademark Office. The USPTO has given the ASCENDIA PHARMA trademark a serial number of 86003276. The federal status of this trademark filing is CANCELLED - SECTION 18 as of Friday, July 26, 2024. This trademark is owned by Ascendia Pharmaceuticals, LLC. The ASCENDIA PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development and research services
ascendia pharma

General Information

Serial Number86003276
Word MarkASCENDIA PHARMA
Filing DateFriday, July 5, 2013
Status713 - CANCELLED - SECTION 18
Status DateFriday, July 26, 2024
Registration Number4614800
Registration DateTuesday, September 30, 2014
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 10, 2013

Trademark Statements

Description of MarkThe mark consists of five folded triangles attached to each other and forming a row, under which are the words "Ascendia Pharma".
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMA"
Goods and ServicesPharmaceutical drug development and research services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code3 - Sec. 18 - Entire Registration
Class Status DateFriday, July 26, 2024
Primary Code042
First Use Anywhere DateFriday, November 1, 2013
First Use In Commerce DateFriday, November 1, 2013

Trademark Owner History

Party NameASCENDIA PHARMACEUTICALS INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNORTH BRUNSWICK, NJ 08902
Party NameAscendia Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNorth Brunswick, NJ 08902
Party NameAscendia Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMonmouth Junction, NJ 08902
Party NameAscendia Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMonmouth Junction, NJ 08902

Trademark Events

Event DateEvent Description
Friday, October 11, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 9, 2013NEW APPLICATION ENTERED
Tuesday, July 16, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 17, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, September 10, 2013ASSIGNED TO EXAMINER
Wednesday, September 11, 2013NON-FINAL ACTION WRITTEN
Wednesday, September 11, 2013NON-FINAL ACTION E-MAILED
Wednesday, September 11, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 11, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 11, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 30, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, October 22, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 7, 2013ASSIGNED TO LIE
Thursday, November 7, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 20, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2013PUBLISHED FOR OPPOSITION
Tuesday, December 10, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 4, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 30, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 30, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 30, 2014USE AMENDMENT FILED
Wednesday, August 20, 2014STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 20, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 28, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 29, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 30, 2014REGISTERED-PRINCIPAL REGISTER
Friday, October 3, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 24, 2017CANCELLATION INSTITUTED NO. 999999
Monday, September 30, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 28, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, December 9, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 14, 2021NOTICE OF SUIT
Tuesday, March 9, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Wednesday, December 15, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, February 14, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED
Saturday, September 30, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, February 14, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 14, 2022NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, April 8, 2022CANCELLATION GRANTED NO. 999999
Tuesday, June 18, 2024CT DECISION: DISMISSED
Friday, July 26, 2024CANCELLATION TERMINATED NO. 999999
Friday, July 26, 2024CANCELLED SECTION 18-TOTAL

Related Keywords

pharma ascendia services research development drug pharmaceutical